MDI: Clinical Trials

10 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 7 Phase 4, 2 Not applicable, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 4	7	Completed 5, Recruiting 1, Unknown 1
Not applicable	2	Completed 2
Phase 3	1	Completed 1

Follow MDI: new trials by email Literature Review of MDI trials Research Report on MDI

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes MDI, AHCL - Type 1 Diabetes	Not applicable	Completed	Medtronic MiniMed, Inc.	122	2020-07-13	2023-03-27
Canadian Real-World Outcomes of Omnipod Initiation in People With T1D Omnipod, MDI - Diabetes Mellitus, Type 1		Completed	LMC Diabetes & Endocrinology Ltd.	286	2020-01-20	2020-02-21
EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES. HCLS, SGLT2 inhibitor, MDI - Type 1 Diabetes		Active not recruiting	Attikon Hospital	100	2019-09-01	2026-10-27
Motility of the Check-cap's MD1 Colon Capsule in Subjects Following Colon Rectal Cancer Screening by Colonoscopy MDI - Colo-rectal Cancer	Not applicable	Completed	Check-Cap Ltd.	88	2019-06-15	2022-01-19
Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice CSII, Multiple dose insulin injections - Type 1 Diabetes Mellitus		Completed	Castilla-La Mancha Health Service	90	2019-01-01	2020-01-18
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	732	2018-06-25	2020-10-28
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	729	2018-06-25	2020-10-28
Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children Nebulizer, Salbutamol, Metered dose inhaler and spacer - Bronchial Asthma	Phase 3	Completed	Suez Canal University	60	2018-05-15	2019-04-04
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) FF/UMEC/VI, Tiotropium, Albuterol/salbutamol - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	800	2018-03-29	2021-07-15
Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients Insulin pump, Insulin injections - Type 1 Diabetes Mellitus	Phase 4	Recruiting	University of Campania Luigi Vanvitelli	150	2016-01-01	2018-03-15
To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma ELLIPTA, DISKUS/ACCUHALER, MDI - Asthma	Phase 4	Completed	GlaxoSmithKline	162	2014-11-01	2015-11-23
Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices ELLIPTA, DISKUS/ACCUHALER, MDI - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	569	2014-08-28	2017-05-23
Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy Transient Continuous Subcutaneous Insulin Infusion, Transient Multiple Daily Insulin Injections - Type 2 Diabetes	Phase 4	Unknown	Shanghai Jiao Tong University School of Medicine	120	2011-12-01	2013-05-06

Conditions studied

Diabetes Mellitus, Type 1 (5)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Asthma (2)  ·  Colonic Neoplasms (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)

Sponsors

GlaxoSmithKline (5)  ·  Attikon Hospital (1)  ·  Castilla-La Mancha Health Service (1)  ·  Check-Cap Ltd. (1)  ·  LMC Diabetes & Endocrinology Ltd. (1)  ·  Medtronic MiniMed, Inc. (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  Suez Canal University (1)  ·  University of Campania Luigi Vanvitelli (1)

Countries

Germany (3)  ·  Netherlands (3)  ·  United Kingdom (3)  ·  United States (3)  ·  Czechia (2)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  France (1)  ·  Greece (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Alaa Zeitoun, Prof (1)  ·  Boaz Shpigelman (1)  ·  Jesus Moreno-Fernandez, PhD (1)  ·  Katherine Esposito (1)  ·  Ronnie Aronson (1)

Results publications

PMID 27883002, PMID 33040383, PMID 35110310, PMID 36058207, PMID 37551542, PMID 37801658

NIH funding

2017 (3)